Skip to content

Study · Animal study (in vivo) · rat · 2012

1 result

[Platelet hyperreactivity and antiaggregatory properties of nootropic drugs under conditions of alloxan-induced diabetes in rats].

Zhiliuk VI, Levykh AÉ, Mamchur VI

Eksperimental'naia i klinicheskaia farmakologiia1 Jan 2012Cited by 1 (Europe PMC)

PMID22702111 (opens in a new tab)PepBankPUB-22702111
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In diabetic rats, Noopept inhibited platelet hyperreactivity under chronic hyperglycemia.

    In plain wordsIn rats with diabetes, Noopept reduced excessive platelet activity during prolonged high blood sugar.

    Peptide
    Noopept (omberacetam)
    Outcome
    DecreasePlatelet hyperreactivity
    Study

    ratsn: not reported in source

    Alloxan-induced diabetes
    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It is established that all these drugs exhibit an inhibitory action of various degrees against platelet hyperreactivity under conditions of chronic hyperglycemia.
    1 context sentence
    Summary · context
    The effects of nootropic drugs (noopept, pentoxifylline, piracetam, pramiracetam, Ginkgo biloba extract, entrop, cerebrocurin and citicoline) on platelet aggregation in rats with experimental diabetes have been studied.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.